Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127069411 | 12706941 | 1 | I | 20090614 | 20090908 | 20160901 | 20160901 | EXP | US-PFIZER INC-2009265706 | PFIZER | 60.00 | YR | M | Y | 104.31000 | KG | 20160901 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127069411 | 12706941 | 1 | PS | IBUPROFEN. | IBUPROFEN | 1 | Oral | UNK UNK, 3X/DAY | Y | 18989 | TABLET | TID | |||||||
| 127069411 | 12706941 | 2 | SS | IBUPROFEN. | IBUPROFEN | 1 | Y | 18989 | TABLET | ||||||||||
| 127069411 | 12706941 | 3 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, 1X/DAY | 5520 | MG | 0 | 20 | MG | CAPSULE | QD | ||||
| 127069411 | 12706941 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | 5520 | MG | 0 | CAPSULE | ||||||||
| 127069411 | 12706941 | 5 | C | ASA | ASPIRIN | 1 | Oral | UNK | 0 | ||||||||||
| 127069411 | 12706941 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | UNK | 0 | ||||||||||
| 127069411 | 12706941 | 7 | C | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | Oral | UNK | 0 | ||||||||||
| 127069411 | 12706941 | 8 | C | PREDNISONE. | PREDNISONE | 1 | Oral | UNK | 0 | ||||||||||
| 127069411 | 12706941 | 9 | C | METOPROLOL. | METOPROLOL | 1 | Oral | UNK | 0 | ||||||||||
| 127069411 | 12706941 | 10 | C | NITROGLYCERINE | NITROGLYCERIN | 1 | Sublingual | UNK | 0 | ||||||||||
| 127069411 | 12706941 | 11 | C | MINOCYCLINE | MINOCYCLINEMINOCYCLINE HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 127069411 | 12706941 | 12 | C | VYTORIN | EZETIMIBESIMVASTATIN | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127069411 | 12706941 | 1 | Osteoarthritis |
| 127069411 | 12706941 | 2 | Rheumatoid arthritis |
| 127069411 | 12706941 | 3 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127069411 | 12706941 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127069411 | 12706941 | Chest pain | |
| 127069411 | 12706941 | Coronary artery stenosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127069411 | 12706941 | 1 | 20080912 | 20120420 | 0 | |
| 127069411 | 12706941 | 3 | 20080912 | 20090614 | 0 | |
| 127069411 | 12706941 | 4 | 20090717 | 0 | ||
| 127069411 | 12706941 | 5 | 20080718 | 0 | ||
| 127069411 | 12706941 | 6 | 20020318 | 0 | ||
| 127069411 | 12706941 | 7 | 20020920 | 0 | ||
| 127069411 | 12706941 | 8 | 20070525 | 0 | ||
| 127069411 | 12706941 | 9 | 20001111 | 0 | ||
| 127069411 | 12706941 | 10 | 20000414 | 0 | ||
| 127069411 | 12706941 | 11 | 20030623 | 0 | ||
| 127069411 | 12706941 | 12 | 20080929 | 0 |